Author

Xue Han

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteORCID 0000-0002-2695-9573Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xue Han2 papers · Center for Life Sciences

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Eric Hong· 1 shared Gang XiniD· 1 shared Haitao Wen· 1 shared Jing Zhao· 1 shared Jun Wang· 1 shared Kareem Alsbei· 1 shared Lawrence Feng· 1 shared Lingbin Meng· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Eric Hong

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The in vivo inhibitory function of the MHC-I alpha3 domain/CD8alpha interaction

Jing Zhao, Lawrence Feng, Yang Xu, Kareem Alsbei, Jun Wang, Tiffany Zhou, Qipeng Zhan, Shiya Sun, Eric Hong, Lingbin Meng, Ning Jin, Xiaolin Cheng, Haitao Wen, Gang Xin, Mark Rubinstein, , Linghua Zheng

This study identifies the MHC-I alpha3 domain-CD8 interaction as an inhibitory pathway that restrains CD8+ T-cell activation and maintains tolerance in vivo.

bioRxiv · May 26, 2026 · PreprintImmunology